International drug pricing model concerns oncologists, others who work with Medicare consumers

Healthcare organizations that represent patients who rely on Medicare Part B drugs have told the Centers for Medicare and Medicaid Services they are concerned over its proposal to save money on drug costs through an international pricing index model.

Continue reading on Healthcare Finance.